BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37589480)

  • 1. Inhibitory interaction of flavonoids with organic anion transporter 3 and their structure-activity relationships for predicting nephroprotective effects.
    Wang FH; Tan HX; Hu JH; Duan XY; Bai WT; Wang XB; Wang BL; Su Y; Hu JP
    J Asian Nat Prod Res; 2024 Mar; 26(3):353-371. PubMed ID: 37589480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects.
    Tan H; Wang F; Hu J; Duan X; Bai W; Wang X; Wang B; Su Y; Hu J
    J Appl Toxicol; 2023 Oct; 43(10):1421-1435. PubMed ID: 37057715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction study of flavonoids toward OATP1B1 and their 3D structure activity relationship analysis for predicting hepatoprotective effects.
    Fan X; Bai J; Hu M; Xu Y; Zhao S; Sun Y; Wang B; Hu J; Li Y
    Toxicology; 2020 May; 437():152445. PubMed ID: 32259555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats.
    Jaikumkao K; Pongchaidecha A; Chattipakorn N; Chatsudthipong V; Promsan S; Arjinajarn P; Lungkaphin A
    Exp Physiol; 2016 Jun; 101(6):743-53. PubMed ID: 27005971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity.
    Wang X; Han L; Li G; Peng W; Gao X; Klaassen CD; Fan G; Zhang Y
    Toxicol Sci; 2018 Feb; 161(2):321-334. PubMed ID: 29045746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Structural Features for the Inhibition of OAT3-Mediated Uptake of Enalaprilat by Selected Drugs and Flavonoids.
    Ni Y; Duan Z; Zhou D; Liu S; Wan H; Gui C; Zhang H
    Front Pharmacol; 2020; 11():802. PubMed ID: 32547398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
    Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
    Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy.
    Li C; Wang X; Bi Y; Yu H; Wei J; Zhang Y; Han L; Zhang Y
    Toxicol Sci; 2020 Jun; 175(2):279-291. PubMed ID: 32159797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
    Iwaki M; Shimada H; Irino Y; Take M; Egashira S
    Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
    Wolman AT; Gionfriddo MR; Heindel GA; Mukhija P; Witkowski S; Bommareddy A; Vanwert AL
    Drug Metab Dispos; 2013 Apr; 41(4):791-800. PubMed ID: 23344796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human organic anion transporters with various cephalosporin antibiotics.
    Takeda M; Babu E; Narikawa S; Endou H
    Eur J Pharmacol; 2002 Mar; 438(3):137-42. PubMed ID: 11909604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of flavonoids on multidrug and toxin extrusion protein 1 function: Implications for food/herb-drug interaction and drug-induced kidney injury.
    Duan X; Bai W; Hu J; Wu J; Tan H; Wang F; Lang X; Wang B; Hu J
    J Appl Toxicol; 2024 May; ():. PubMed ID: 38760888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Drug Transporters and Drug Interactions.
    Ivanyuk A; Livio F; Biollaz J; Buclin T
    Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
    Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation.
    Erman F; Tuzcu M; Orhan C; Sahin N; Sahin K
    Biol Trace Elem Res; 2014 Apr; 158(1):90-5. PubMed ID: 24531880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
    Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
    Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion transporter 3 (OAT3)-mediated transport of dicaffeoylquinic acids and prediction of potential drug-drug interaction.
    Wang Y; Ren J; Sun Q; Zhang Z; Lin Y; Deng S; Wang C; Huo X; Sun C; Tian X; Zhang B; Feng L; Ma X
    Eur J Pharm Sci; 2019 May; 133():95-103. PubMed ID: 30928510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.